SLC40A1⁺ macrophages contribute to the immunosuppressive tumor microenvironment in EGFR-mutated lung cancer

Affiliations

• ¹ Department of Medical Oncology, Qilu Hospital of Shandong University, Jinan 250012, China; Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
• ² Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
• ³ Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
• ⁴ Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
• ⁵ Department of Pathology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China.
• ⁶ Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Electronic address: harry_ren@126.com.
• ⁷ Department of Medical Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China. Electronic address: caicunzhoudr@163.com.
• ⁸ Department of Medical Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai 200433, China. Electronic address: fywu@163.com.